BioLife Solutions to Unveil 2025 Results and Strategic Update Feb. 26

BenzingaBenzinga
|||1 min read
Key Takeaway

BioLife Solutions will release 2025 financial results and host a conference call on February 26, 2026, discussing earnings and strategic updates for its cell therapy preservation business.

BioLife Solutions to Unveil 2025 Results and Strategic Update Feb. 26

BioLife Solutions Inc. (NASDAQ: BLFS) has scheduled the release of its fourth quarter and full-year 2025 financial results for February 26, 2026. The company will present its earnings report followed by a live conference call and webcast beginning at 4:30 p.m. Eastern Time, during which senior management will review the company's financial performance and operational achievements throughout the year.

Investors and analysts will have the opportunity to hear directly from BioLife Solutions leadership regarding the company's results and strategic direction. The live webcast will be available to the public, with details on accessing the call expected to be provided in advance of the scheduled announcement.

BioLife Solutions, which specializes in preservation and storage solutions for cellular and gene therapies, continues to serve a critical role in the biopharmaceutical supply chain. The company's earnings call will offer insight into its performance amid growing demand in the cell and gene therapy sectors.

Source: Benzinga

Back to newsPublished Feb 17

Related Coverage

GlobeNewswire Inc.

Sika AG Shareholders Approve Board, Boost Dividend to CHF 3.70 Per Share

Sika AG shareholders approved CHF 3.70 dividend and board re-election at 2026 AGM, with company reporting CHF 11.20B sales and 33,700 employees globally.

SXYAY
GlobeNewswire Inc.

17EdTech Posts Narrower Loss Despite Revenue Decline as AI Product Gains Traction

17EdTech reports Q4 revenue growth of 6.4% YoY and significant margin expansion, though full-year revenues declined 44% due to business model shift. New AI product 'Yiqi Aixue' shows strong pre-sale demand.

YQ
The Motley Fool

Slide Insurance Posts $444M Profit on Strong Revenue Growth; Insider Trims Position

Slide Insurance reported $444M net income and $1.16B revenue, up 36% YoY. Director sold $1M in shares via pre-arranged plan while maintaining substantial stake.

SLDE
Benzinga

Alfa Laval Sets Q1 2026 Earnings Release; Conference Call Scheduled for April 22

Alfa Laval will release Q1 2026 earnings April 22, 2026, followed by investor conference call hosted by CEO Tom Erixon and CFO Fredrik Ekström.

ALFVY
GlobeNewswire Inc.

IMUNON Sets March 31 Call to Detail 2025 Results, OVATION 3 Trial Progress

$IMNN to discuss 2025 results and OVATION 3 Phase 3 trial progress for IMNN-001 ovarian cancer immunotherapy on March 31, 2026.

IMNN
GlobeNewswire Inc.

GEN Restaurant Group to Report 2025 Results as Korean BBQ Chain Expands

$GENK to discuss Q4 and full-year 2025 earnings on March 31, 2026, with 59+ company-owned locations driving growth.

GENK